share_log

Ladenburg Thalmann Upgrades Forte Biosciences to Buy, Announces $2.75 Price Target

Benzinga ·  Apr 8 17:36

Ladenburg Thalmann analyst Michael Higgins upgrades Forte Biosciences (NASDAQ:FBRX) from Neutral to Buy and announces $2.75 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment